Paul Lévesque
Amministratore Delegato presso THERATECHNOLOGIES INC.
Patrimonio netto: 91 000 $ in data 31/05/2024
Profilo
Paul Lévesque is currently the President, Chief Executive Officer & Director at Theratechnologies, Inc. He previously worked as the Global President-Rare Disease at Pfizer Inc. from 2018 to 2020.
Prior to that, he held the position of Vice President-France & Canada Marketing at PF Consumer Healthcare Canada ULC.
Mr. Lévesque completed his undergraduate degree at McGill University and Université Laval.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
THERATECHNOLOGIES INC.
0.16% | 21/01/2024 | 72 800 ( 0.16% ) | 91 000 $ | 31/05/2024 |
Posizioni attive di Paul Lévesque
| Società | Posizione | Inizio |
|---|---|---|
| THERATECHNOLOGIES INC. | Amministratore Delegato | 06/04/2020 |
Precedenti posizioni note di Paul Lévesque
| Società | Posizione | Fine |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 06/04/2020 |
PF Consumer Healthcare Canada ULC
 PF Consumer Healthcare Canada ULC Pharmaceuticals: MajorHealth Technology PF Consumer Healthcare Canada ULC produces anti-infective, anti-inflammatory, cardiovascular and other prescription medicines and consumer healthcare products. It discovers, develops, manufactures and markets prescription medicines for humans and animals as well as over-the-counter healthcare products. The company was founded in 1953 and is headquartered in Kirkland, Canada. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Paul Lévesque
| Université Laval | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| THERATECHNOLOGIES INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
PF Consumer Healthcare Canada ULC
PF Consumer Healthcare Canada ULC Pharmaceuticals: MajorHealth Technology PF Consumer Healthcare Canada ULC produces anti-infective, anti-inflammatory, cardiovascular and other prescription medicines and consumer healthcare products. It discovers, develops, manufactures and markets prescription medicines for humans and animals as well as over-the-counter healthcare products. The company was founded in 1953 and is headquartered in Kirkland, Canada. | Health Technology |
- Borsa valori
- Insiders
- Paul Lévesque
